Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIAA0232 protein is a large (1395 amino acids; 154.8 kDa), highly phosphorylated nuclear protein encoded by the KIAA0232 gene on chromosome 4p16.1. It features a DUF4603 domain of unknown function and is predicted to bind ATP. Expression is widespread but particularly high in the brain, and the protein is evolutionarily conserved among animals. Experimental data and GWAS suggest possible biological roles in platelet count regulation, megakaryocyte biology, and modulation of beta-cell function and insulin secretion. KIAA0232 interacts experimentally with proteins such as YWHAZ and DYRK1A/B, linking it to cellular signaling pathways, but is not currently considered a validated therapeutic target or druggable receptor/enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KIAA0232 protein (KIAA0232).